Schnabel RB, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62.

Article  Google Scholar 

Chugh SS, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.

Article  Google Scholar 

Van Wagoner DR, et al. Atrial L-type Ca2 + currents and human atrial fibrillation. Circul Res. 1999;85(5):428–36.

Article  Google Scholar 

Landstrom AP, Dobrev D, Wehrens XH. Calcium signaling and cardiac arrhythmias. Circul Res. 2017;120(12):1969–93.

Article  Google Scholar 

Greer-Short A, et al. Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia. Heart rhythm. 2020;17(3):503–11.

Article  Google Scholar 

Voigt N, et al. Enhanced sarcoplasmic reticulum Ca2 + leak and increased Na+-Ca2 + exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation. 2012;125(17):2059–70.

Article  Google Scholar 

Schotten U, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265–325.

Article  Google Scholar 

Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Res. 2002;54(2):230–46.

Article  Google Scholar 

Rudolph V, et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med. 2010;16(4):470–4.

Article  Google Scholar 

Alasady M, et al. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circulation: Arrhythmia Electrophysiol. 2013;6(4):738–45.

Google Scholar 

Soliman EZ, et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation. Hypertension. 2020;75(6):1491–6.

Article  Google Scholar 

Echouffo-Tcheugui JB, et al. Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry. J Am Coll Cardiol. 2017;70(11):1325–35.

Article  Google Scholar 

Wong C, Sullivan T, Sun M. Obesity and the risk of incident, post-operative, and post‐ablation atrial fibrillation. JACC: Clin Electrophysiol. 2015;1(3):139–52.

Google Scholar 

Kaakeh Y, et al. Drug-induced atrial fibrillation. Drugs. 2012;72:1617–30.

Article  Google Scholar 

Chen P-S, et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circul Res. 2014;114(9):1500–15.

Article  Google Scholar 

Van Der Hooft CS, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med. 2006;166(9):1016–20.

Article  Google Scholar 

Oster MW, Rakowski TJ. Myocardial injury immediately following adriamycin administration. Med Pediatr Oncol. 1981;9(5):463–5.

Article  Google Scholar 

Montella L, et al. Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease). Ann Hematol. 2005;84:p192–193.

Article  Google Scholar 

Vrints C, et al. 2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3415–537.

Article  Google Scholar 

Byrne RA, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart Journal: Acute Cardiovasc Care. 2024;13(1):55–161.

Google Scholar 

Virani SS et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 2023. 82(9): pp. 833–955.

Members W.C., et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;79(2):e21–129.

Google Scholar 

Collet J-P, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2020;42(14):1289–367.

Article  Google Scholar 

Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Esp de cardiologia (English ed). 2017;70(12):p1082.

Google Scholar 

Levine GN, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67(10):1235–50.

Article  Google Scholar 

Amsterdam EA, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.

Article  Google Scholar 

O’gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140.

Article  Google Scholar 

Jneid H, et al. 2012 accf/aha focused update of the guideline for the management of patients with unstable angina/non–st-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update) a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2012;60(7):645–81.

Article  Google Scholar 

Fihn SD et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 2012. 60(24): pp. e44-e164.

Smith SC, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58(23):2432–46.

Article  Google Scholar 

Levine GN et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Journal of the American College of Cardiology, 2011. 58(24): pp. e44-e122.

Hillis LD et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 2011. 58(24): pp. e123-e210.

Smith SC Jr, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363–72.

Article  Google Scholar 

Smith SC, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38(5):1581–3.

Article  Google Scholar 

Choi E-K. Cardiovascular research using the Korean national health information database. Korean circulation J. 2020;50(9):754–72.

Article  Google Scholar 

Yeo M, et al. Proteinuria and the risk of Incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study. Cardiovasc Diabetol. 2025;24(1):41.

Article  MathSciNet  Google Scholar 

Lee H, et al. The trends of atrial fibrillation-related hospital visit and cost, treatment pattern and mortality in Korea: 10-year nationwide sample cohort data. Korean circulation J. 2017;47(1):56–64.

Article  Google Scholar 

Kim D, et al. Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. Heart. 2018;104(24):2010–7.

Article  Google Scholar 

Cox DR. Regression models and life-tables. J Roy Stat Soc: Ser B (Methodol). 1972;34(2):187–202.

Article  MathSciNet  Google Scholar 

Gennari FJ. Hypokalemia New Engl J Med. 1998;339(7):451–8.

Article  Google Scholar 

Krijthe BP, et al. Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013;168(6):5411–5.

Article  Google Scholar 

Lu Y-Y, et al. Electrolyte disturbances differentially regulate sinoatrial node and pulmonary vein electrical activity: a contribution to hypokalemia-or hyponatremia-induced atrial fibrillation. Heart rhythm. 2016;13(3):781–8.

Article  MathSciNet  Google Scholar 

McManus DD, et al. Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol. 2011;10(1):46–51.

Article  Google Scholar 

Mentz RJ, et al. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Future Cardiol. 2015;11(5):585–95.

Article  Google Scholar 

Nouhravesh N, et al. Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial. Eur J Heart Fail. 2025;27(2):317–24.

Article  Google Scholar 

Yan T, et al. Coronary artery disease and atrial fibrillation: a bidirectional Mendelian randomization study. J Cardiovasc Dev Disease. 2022;9(3):69.

Article  Google Scholar 

Frederiksen TC, et al. Bidirectional association between atrial fibrillation and myocardial infarction, and relation to mortality in the Framingham Heart Study. J Am Heart Association. 2024;13(11):e032226.

Article  Google Schola